Helmut
★★★
avatar
Homepage
Vienna, Austria,
2005-08-16 15:03
(6437 d 17:34 ago)

(edited by HS on 2007-08-24 14:22)
Posting: # 22
Views: 14,008
 

 Updated Canadian Guidelines [Regulatives / Guidelines]

Dear all!

Canada's HPFB published a new set of Documents:
  • 12 May 2004, DRAFT GUIDANCE FOR INDUSTRY
    Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format (91kB PDF)
  • 28 May 2004, DRAFT GUIDANCE FOR INDUSTRY
    Use of Metabolite Data in Comparative Bioavailability Studies (27kB PDF)
  • 03 June 2005, NOTICE TO INDUSTRY
    Bioequivalence Requirements for Combination Drug Products (12kB PDF)
  • 08 June 2004, GUIDANCE FOR INDUSTRY
    Bioequivalence Requirements: Comparative Bioavailability Studies Conducted in the Fed State (25kB PDF)
  • 22 June 2005, NOTICE TO INDUSTRY
    Bioequivalence Requirements for Long Half-life Drugs (13kB PDF)
  • 22 June 2005, NOTICE TO INDUSTRY
    Bioequivalence Requirements for Drugs for Which an Early Time of Onset or Rapid Rate of Absorption Is Important (rapid onset drugs)
    (15kB PDF)
  • 31 May 2006, GUIDANCE FOR INDUSTRY
    Bioequivalence Requirements: Critical Dose Drugs (38kB PDF)
HTML-Versions of all Documents

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
22,560 posts in 4,725 threads, 1,607 registered users;
15 visitors (0 registered, 15 guests [including 8 identified bots]).
Forum time: 08:37 CEST (Europe/Vienna)

No written law has ever been more binding than
unwritten custom supported by popular opinion.    Carrie Chapman Catt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5